These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 38061436)

  • 1. Identification and structural analysis of dimeric chicken complement component 3d and its binding with chicken complement receptor 2.
    Jin H; Tu M; Meng Z; Jiang B; Yang Q; Li Y; Zhang Z
    Dev Comp Immunol; 2024 Mar; 152():105109. PubMed ID: 38061436
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification and Characterization of chCR2, a Protein That Binds Chicken Complement Component 3d.
    Jin H; Kong Z; Jiang B; Tu M; Xu J; Cheng J; Liu W; Zhang Z; Li Y
    J Immunol; 2023 May; 210(9):1408-1418. PubMed ID: 36971659
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Construction, expression and immunoassay detection of recombinant plasmid encoding fusion protein of Roman chicken complement C3d and Newcastle disease virus F gene.
    Liu D; Niu ZX
    Scand J Immunol; 2008 Dec; 68(6):598-606. PubMed ID: 19055698
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fusion of Ross chicken complement component C3d-P29 repeats with a chicken viral Newcastle disease virus F gene enhances immune responses following DNA immunization.
    Liu D; Niu ZX
    Viral Immunol; 2009 Jun; 22(3):221-31. PubMed ID: 19435419
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cloning of a gene fragment encoding chicken complement component C3d with expression and immunogenicity of Newcastle disease virus F gene-C3d fusion protein.
    Liu D; Niu ZX
    Avian Pathol; 2008 Oct; 37(5):477-85. PubMed ID: 18798021
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural studies in solution of the recombinant N-terminal pair of short consensus/complement repeat domains of complement receptor type 2 (CR2/CD21) and interactions with its ligand C3dg.
    Guthridge JM; Rakstang JK; Young KA; Hinshelwood J; Aslam M; Robertson A; Gipson MG; Sarrias MR; Moore WT; Meagher M; Karp D; Lambris JD; Perkins SJ; Holers VM
    Biochemistry; 2001 May; 40(20):5931-41. PubMed ID: 11352728
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Solution structure of the complex between CR2 SCR 1-2 and C3d of human complement: an X-ray scattering and sedimentation modelling study.
    Gilbert HE; Eaton JT; Hannan JP; Holers VM; Perkins SJ
    J Mol Biol; 2005 Feb; 346(3):859-73. PubMed ID: 15713468
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Delineation of the complement receptor type 2-C3d complex by site-directed mutagenesis and molecular docking.
    Shaw CD; Storek MJ; Young KA; Kovacs JM; Thurman JM; Holers VM; Hannan JP
    J Mol Biol; 2010 Dec; 404(4):697-710. PubMed ID: 20951140
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The molecular mechanism of pH-regulating C3d-CR2 interactions: Insights from molecular dynamics simulation.
    Zhang Y; Guo J; Ning L; Tian J; Yao X; Liu H
    Chem Biol Drug Des; 2019 Apr; 93(4):628-637. PubMed ID: 30566277
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular dynamics simulations of wild type and mutants of human complement receptor 2 complexed with C3d.
    Wan H; Hu JP; Tian XH; Chang S
    Phys Chem Chem Phys; 2013 Jan; 15(4):1241-51. PubMed ID: 23229122
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunogenicity of a chicken viral Newcastle disease virus F gene-C3d fusion protein containing a chicken homologue of C3d.
    Liu D; Niu ZX
    Viral Immunol; 2008 Sep; 21(3):389-98. PubMed ID: 18788947
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Solution structure of the complex formed between human complement C3d and full-length complement receptor type 2.
    Li K; Okemefuna AI; Gor J; Hannan JP; Asokan R; Holers VM; Perkins SJ
    J Mol Biol; 2008 Dec; 384(1):137-50. PubMed ID: 18804116
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The solvent at antigen-binding site regulated C3d-CR2 interactions through the C-terminal tail of C3d at different ion strengths: insights from molecular dynamics simulation.
    Zhang Y; Guo J; Li L; Liu X; Yao X; Liu H
    Biochim Biophys Acta; 2016 Oct; 1860(10):2220-31. PubMed ID: 27154286
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kinetic analysis of the interactions of complement receptor 2 (CR2, CD21) with its ligands C3d, iC3b, and the EBV glycoprotein gp350/220.
    Sarrias MR; Franchini S; Canziani G; Argyropoulos E; Moore WT; Sahu A; Lambris JD
    J Immunol; 2001 Aug; 167(3):1490-9. PubMed ID: 11466369
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure of complement receptor (CR) 2 and CR2-C3d complexes.
    Hannan J; Young K; Szakonyi G; Overduin MJ; Perkins SJ; Chen X; Holers VM
    Biochem Soc Trans; 2002 Nov; 30(Pt 6):983-9. PubMed ID: 12440958
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutational analysis of the complement receptor type 2 (CR2/CD21)-C3d interaction reveals a putative charged SCR1 binding site for C3d.
    Hannan JP; Young KA; Guthridge JM; Asokan R; Szakonyi G; Chen XS; Holers VM
    J Mol Biol; 2005 Feb; 346(3):845-58. PubMed ID: 15713467
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neutrophils express a receptor for iC3b, C3dg, and C3d that is distinct from CR1, CR2, and CR3.
    Vik DP; Fearon DT
    J Immunol; 1985 Apr; 134(4):2571-9. PubMed ID: 3156185
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cloning and structural analysis of complement component 3d in wild birds provides insight into its functional evolution.
    Jiang B; Zhang Z; Xu J; Jin H; Tuya ; Li Y
    Dev Comp Immunol; 2021 Apr; 117():103979. PubMed ID: 33338517
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutational analyses reveal that the staphylococcal immune evasion molecule Sbi and complement receptor 2 (CR2) share overlapping contact residues on C3d: implications for the controversy regarding the CR2/C3d cocrystal structure.
    Isenman DE; Leung E; Mackay JD; Bagby S; van den Elsen JM
    J Immunol; 2010 Feb; 184(4):1946-55. PubMed ID: 20083651
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A theoretical view of the C3d:CR2 binding controversy.
    Mohan RR; Gorham RD; Morikis D
    Mol Immunol; 2015 Mar; 64(1):112-22. PubMed ID: 25433434
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.